Noteworthy is that the health benefits of a concerted upregulation of BHMT-1, MAT-1, and GNMT by betaine treatment could counter their collective downregulation in human hepatocellular carcinoma [22]. The gene discussed is BHMT; the disease is hepatocellular carcinoma.